These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8930673)

  • 1. A novel mechanism for virus-induced autoimmunity in humans.
    Nauclér CS; Larsson S; Möller E
    Immunol Rev; 1996 Aug; 152():175-92. PubMed ID: 8930673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
    Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
    Soderberg C; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):594-600. PubMed ID: 8610387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission.
    Larsson S; Söderberg-Nauclér C; Möller E
    Transplantation; 1998 Feb; 65(3):411-5. PubMed ID: 9484762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
    Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases and autoimmunity post-bone marrow transplantation.
    Sherer Y; Shoenfeld Y
    Bone Marrow Transplant; 1998 Nov; 22(9):873-81. PubMed ID: 9827815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of human cytomegalovirus by human CD13-specific antibodies.
    Giugni TD; Söderberg C; Ham DJ; Bautista RM; Hedlund KO; Möller E; Zaia JA
    J Infect Dis; 1996 May; 173(5):1062-71. PubMed ID: 8627055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
    Cuvelier GD; Kariminia A; Fujii H; Aslanian S; Wall D; Goldman F; Grupp SA; Dunn SE; Krailo M; Shapiro LH; Gilman A; Schultz KR
    Bone Marrow Transplant; 2010 Nov; 45(11):1653-7. PubMed ID: 20190833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients.
    Finny GJ; Mathews V; Abraham P; Abraham M; Chandy M; Srivastava A; Nitsche A; Siegert W; Sridharan G
    Indian J Med Res; 2001 Aug; 114():39-46. PubMed ID: 11785448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization.
    Link H; Battmer K; Stumme C
    Br J Haematol; 1993 Nov; 85(3):573-7. PubMed ID: 8136281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
    Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant herpes virus serology and chronic graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
    Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus immunity in allogeneic marrow grafting.
    Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
    Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
    Bowden RA; Day LM; Amos DE; Meyers JD
    Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
    Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
    Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.